Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
murlentamab (GM102)
i
Other names:
GM102, GM 102, 3C23K
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Exelixis
Drug class:
AMHR2 antagonist
‹
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
AMHR2 expression
Colorectal Cancer
AMHR2 expression
Colorectal Cancer
GM102
Sensitive: D – Preclinical
GM102
Sensitive
:
D
GM102
Sensitive: D – Preclinical
GM102
Sensitive
:
D
AMHR2 expression
Hepatocellular Cancer
AMHR2 expression
Hepatocellular Cancer
GM102
Sensitive: D – Preclinical
GM102
Sensitive
:
D
GM102
Sensitive: D – Preclinical
GM102
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login